About the Authors
- Juerg Barben
-
* E-mail: juerg.barben@kispisg.ch
Affiliation Department of Paediatric Pulmonology & Allergology, Children’s Hospital, St. Gallen, Switzerland
- Marie-Pierre F. Strippoli
-
Affiliation Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
- Daniel Trachsel
-
Affiliation Department of Pulmonology and Intensive Care, University Children’s Hospital Basel, Basel, Switzerland
- Barbara Schiller
-
Affiliation Department of Paediatric Pulmonology & Allergology, Children’s Hospital, St. Gallen, Switzerland
- Juerg Hammer
-
Affiliation Department of Pulmonology and Intensive Care, University Children’s Hospital Basel, Basel, Switzerland
- Claudia E. Kuehni
-
Affiliation Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland
Competing Interests
The authors would like to declare commercial funder AstraZeneca (Switzerland) as a competing interest. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Editing and review of the manuscript: JB MPS DT BS JH CEK. Conceived and designed the experiments: JB DT JH CEK. Performed the experiments: JB DT BS JH. Analyzed the data: MPS CEK. Contributed reagents/materials/analysis tools: JB. Wrote the paper: JB MPS CEK.